OSLO, NORWAY--(Marketwired - August 19, 2013) - Algeta ASA (OSE: ALGETA), a company focused
the development of novel targeted cancer therapeutics, will announce its
half and second quarter 2013 results on Wednesday, 28 August
presentation by members of Algeta's executive management team to
analysts and the press will take place in Oslo at 10:00 CET.
The presentation will also be webcast live and can be accessed
www.algeta.com where questions can also be submitted during the
The presentation will take place at 10:00 CET at:
Haakon VIIs gate 9
Algeta will also host an international conference call at 14:30
Eastern Time (US) (details below).
To participate in the conference call, please dial the appropriate number
five minutes prior to the call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 197187#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 348084#
A replay of the conference call will also be available at www.algeta.com.
The results report and the presentation will be available at
the Investors section from 07:00 CET.
Algeta is a company focused on developing novel targeted therapies for
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
Cambridge, MA performing commercial marketing operations in the US. Algeta
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE